Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on February 4, 2008

Circulation. 2008
Published online before print February 4, 2008, doi: 10.1161/CIRCULATIONAHA.107.733220
A more recent version of this article appeared on February 19, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/7/915    most recent
CIRCULATIONAHA.107.733220v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willmann, J. K.
Right arrow Articles by Gambhir, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willmann, J. K.
Right arrow Articles by Gambhir, S. S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Nuclear Scans
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Angiogenesis
Right arrow Animal models of human disease
Right arrow Imaging
Right arrow Peripheral vascular disease
Right arrow Exercise/exercise testing/rehabilitation
Right arrow Nuclear cardiology and PET
Right arrowRelated Article

Submitted on August 10, 2007
Accepted on December 7, 2007

Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography

Jürgen K. Willmann MD, Kai Chen PhD, Hui Wang PhD, Ramasamy Paulmurugan PhD, Mark Rollins MD, PhD, Weibo Cai PhD, David S. Wang MD, Ian Y. Chen MSE, Olivier Gheysens MD, Martin Rodriguez-Porcel MD, Xiaoyuan Chen PhD, and Sanjiv S. Gambhir MD, PhD*

From The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program (J.K.W., K.C., H.W., R.P., W.C., D.S.W., I.Y.C., O.G., M.R.-P., X.C., S.S.G.), and Department of Bioengineering (I.Y.C., S.S.G.), Stanford University School of Medicine, Stanford, Calif; and Department of Anesthesia and Perioperative Care (M.R.), University of California at San Francisco, San Francisco.

* To whom correspondence should be addressed. E-mail: sgambhir{at}stanford.edu.

Background—Vascular endothelial growth factor-121 (VEGF121), an angiogenic protein secreted in response to hypoxic stress, binds to VEGF receptors (VEGFRs) overexpressed on vessels of ischemic tissue. The purpose of this study was to evaluate 64Cu-VEGF121 positron emission tomography for noninvasive spatial, temporal, and quantitative monitoring of VEGFR2 expression in a murine model of hindlimb ischemia with and without treadmill exercise training.

Methods and Results64Cu-labeled VEGF121 and a VEGF mutant were tested for VEGFR2 binding specificity in cell culture. Mice (n=58) underwent unilateral ligation of the femoral artery, and postoperative tissue ischemia was assessed with laser Doppler imaging. Longitudinal VEGFR2 expression in exercised and nonexercised mice was quantified with 64Cu-VEGF121 positron emission tomography at postoperative day 8, 15, 22, and 29 and correlated with postmortem {gamma}-counting. Hindlimbs were excised for immunohistochemistry, Western blotting, and microvessel density measurements. Compared with the VEGF mutant, VEGF121 showed specific binding to VEGFR2. Perfusion in ischemic hindlimbs fell to 9% of contralateral hindlimb on postoperative day 1 and recovered to 82% on day 29. 64Cu-VEGF121 uptake in ischemic hindlimbs increased significantly (P<0.001) from a control level of 0.61±0.17% ID/g (percentage of injected dose per gram) to 1.62±0.35% ID/g at postoperative day 8, gradually decreased over the following 3 weeks (0.59±0.14% ID/g at day 29), and correlated with {gamma}-counting (R2=0.99). Compared with nonexercised mice, 64Cu-VEGF121 uptake was increased significantly (P≤0.0001) in exercised mice (at day 15, 22, and 29) and correlated with VEGFR2 levels as obtained by Western blotting (R2=0.76). Ischemic hindlimb tissue stained positively for VEGFR2. In exercised mice, microvessel density was increased significantly (P<0.001) compared with nonexercised mice.

Conclusions64Cu-VEGF121 positron emission tomography allows longitudinal spatial and quantitative monitoring of VEGFR2 expression in murine hindlimb ischemia and indirectly visualizes enhanced angiogenesis stimulated by treadmill exercise training.


Key words: imaging • arteriosclerosis • exercise • angiogenesis • tomography • peripheral vascular disease • growth substances


Related Article:

Clinical Summaries
Circulation 2008 117: 857-859. [Full Text]